{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:11:15Z","timestamp":1789726275212,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173253"],"award-info":[{"award-number":["82173253"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2023HBXH096"],"award-info":[{"award-number":["2023HBXH096"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.dld.2025.03.002","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T14:39:59Z","timestamp":1742827199000},"page":"1377-1385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Glucagon-like peptide-1 receptor agonists increase the risk of residual gastric content and pulmonary aspiration on upper endoscopy: A meta-analysis"],"prefix":"10.1016","volume":"57","author":[{"given":"Ying","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-He","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7820-6920","authenticated-orcid":false,"given":"Xue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.dld.2025.03.002_bib0001","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1210\/clinem\/dgac276","article-title":"Slow and steady wins the race: 25 years developing the GLP-1 receptor as an effective target for weight loss","volume":"107","author":"Kumar","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.dld.2025.03.002_bib0002","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s12325-021-01710-0","article-title":"Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists","volume":"38","author":"Ard","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.dld.2025.03.002_bib0003","article-title":"Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study","author":"Wu","year":"2024","journal-title":"Canadian Journal of Anesthesia"},{"key":"10.1016\/j.dld.2025.03.002_bib0004","article-title":"Increased risk of aspiration pneumonia associated with endoscopic procedures among patients with Glucagon-like peptide-1 receptor agonist use","author":"Yeo","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.03.002_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2024.04.2900","article-title":"Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and non-diabetic patients","author":"Nadeem","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2025.03.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2023.111091","article-title":"Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy","volume":"87","author":"Silveira","year":"2023","journal-title":"J Clin Anesth"},{"issue":"2","key":"10.1016\/j.dld.2025.03.002_bib0007","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/ALN.0000000000004776","article-title":"ASA consensus-based guidance on preoperative management of patients on glucagon-like peptide-1 receptor agonists","volume":"140","author":"Ushakumari","year":"2024","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.dld.2025.03.002_bib0008","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cgh.2023.11.002","article-title":"AGA rapid clinical practice update on the management of patients taking GLP-1 receptor agonists prior to endoscopy: communication","volume":"22","author":"Hashash","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.03.002_bib0009","article-title":"Effects of glucagon-like peptide-1 receptor agonists on upper gastrointestinal endoscopy: a meta-analysis","author":"Facciorusso","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.03.002_bib0010","article-title":"Glucagon-like peptide-1 receptor agonist use and the risk of residual gastric content and aspiration in patients undergoing gastrointestinal endoscopy: a systematic review and a meta-analysis","author":"Baig","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2025.03.002_bib0011","article-title":"Effects of glucagon-like peptide-1 receptor agonists on endoscopy outcomes: systematic review and meta-analysis","author":"Singh","year":"2024","journal-title":"Gastrointest Endosc"},{"issue":"8","key":"10.1016\/j.dld.2025.03.002_bib0012","article-title":"Risk of aspiration pneumonitis after elective esophagogastroduodenoscopy in patients on glucagon-like peptide-1 receptor agonists","volume":"16","author":"RaS","year":"2024","journal-title":"Cureus J Med Sci"},{"issue":"6","key":"10.1016\/j.dld.2025.03.002_bib0013","doi-asserted-by":"crossref","first-page":"AB150","DOI":"10.1016\/j.gie.2024.04.943","article-title":"Incidence of aspiration pneumonitis and emergent intubation in patients on glucagon-like peptide-1 inhibitors undergoing upper endoscopy and colonoscopy: a comparative study","volume":"99","author":"Kumar","year":"2024","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.dld.2025.03.002_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.dld.2025.03.002_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2458-13-154","article-title":"Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review","volume":"13","author":"Herzog","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.dld.2025.03.002_bib0016","first-page":"343","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","author":"Higgins","year":"2011","journal-title":"Bmj-Brit Med J"},{"issue":"10","key":"10.1016\/j.dld.2025.03.002_bib0017","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2025.03.002_bib0018","first-page":"343","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","author":"JaC","year":"2011","journal-title":"Bmj-Brit Med J"},{"key":"10.1016\/j.dld.2025.03.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111900","article-title":"The impact of glucagon-like peptide-1 receptor agonist on the gastric residue in upper endoscopy","volume":"217","author":"Abu-Freha","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"issue":"6S","key":"10.1016\/j.dld.2025.03.002_bib0020","doi-asserted-by":"crossref","first-page":"AB367","DOI":"10.1016\/j.gie.2024.04.1271","article-title":"The impact of glucagon-like peptide-1 receptor agonists use prior to esophagogastroduodenoscopy","volume":"99","author":"Ayoub","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2025.03.002_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2024.05.012","article-title":"Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during esophagogastroduodenoscopy","author":"Chapman","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2025.03.002_bib0022","doi-asserted-by":"crossref","first-page":"AB173","DOI":"10.1016\/j.gie.2024.04.983","article-title":"Low rates of gastric food retention during endoscopy in patients on glucagon-like-peptide-1 receptor agonists at a large academic center","author":"Dev","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2025.03.002_bib0023","article-title":"Rates of repeat EGD in nondiabetic adults with glucagon-like peptide-1 receptor agonist prescription: a retrospective matched cohort study","author":"Elangovan","year":"2024","journal-title":"Gastrointest Endosc"},{"issue":"9","key":"10.1016\/j.dld.2025.03.002_bib0024","first-page":"e69152","article-title":"Confounding factors in the association between glucagon-like peptide-1 receptor agonist use and retained gastric contents in asymptomatic patients undergoing upper gastrointestinal endoscopy: a retrospective study","volume":"16","author":"Elimihele","year":"2024","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.dld.2025.03.002_bib0025","doi-asserted-by":"crossref","first-page":"S624","DOI":"10.14309\/01.ajg.0001032952.21205.89","article-title":"GLP-1 receptor agonists and retained gastric content in type 2 diabetics: insights from a retrospective endoscopic analysis, A preliminary study","volume":"119","author":"Elliott","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.03.002_bib0026","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000002777","article-title":"Glucagon-like peptide-1 receptor agonists increase solid gastric residue rates on upper endoscopy especially in patients with complicated diabetes: a case-control study","author":"Garza","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.dld.2025.03.002_bib0027","doi-asserted-by":"crossref","first-page":"S611","DOI":"10.14309\/01.ajg.0001032888.40013.2e","article-title":"Risk of aspiration for patients on GLP-1 agonists undergoing EGD","volume":"119","author":"Gioe","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"18","key":"10.1016\/j.dld.2025.03.002_bib0028","article-title":"Real-world impact of GLP-1 receptor agonists on endoscopic patient outcomes in an ambulatory setting: a retrospective study at a large tertiary center","volume":"13","author":"Gonzaga","year":"2024","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.dld.2025.03.002_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(24)01844-4","article-title":"The impact of semaglutide on retained gastric contents during endoscopy","volume":"166","author":"Gu","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.03.002_bib0030","doi-asserted-by":"crossref","unstructured":"Hernandez L, Ukwade D, Modi Z, et al. Receptor agonist effect on retained gastric contents on EGD: a quality improvement study. 2024:AB279.","DOI":"10.1016\/j.gie.2024.04.1171"},{"issue":"10","key":"10.1016\/j.dld.2025.03.002_bib0031","doi-asserted-by":"crossref","first-page":"S598","DOI":"10.14309\/01.ajg.0001032824.49982.9d","article-title":"Clinical impact of GLP-1RA on endoscopy: a retrospective cohort study in endoscopy patients","volume":"119","author":"Karlson","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.dld.2025.03.002_bib0032","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/jdi.14005","article-title":"Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy","volume":"14","author":"Kobori","year":"2023","journal-title":"J Diabetes Investig"},{"issue":"4","key":"10.1016\/j.dld.2025.03.002_bib0033","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.tige.2024.07.001","article-title":"Semaglutide is an independent predictor of retained solid gastric contents, but same-day colonoscopy mitigates effect. Techniques and innovations in","volume":"26","author":"Korlipara","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2025.03.002_bib0034","doi-asserted-by":"crossref","first-page":"AB1139","DOI":"10.1016\/j.gie.2024.04.2871","article-title":"Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use predicts retained gastric contents but not increased risk of major adverse anesthesia-related events during upper endoscopy","author":"Markley","year":"2024","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"10.1016\/j.dld.2025.03.002_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(24)03194-9","article-title":"Increased risk of residual gastric content in patients on GLP-1 agonists undergoing esophagogastroduodenoscopy","volume":"166","author":"Meluban","year":"2024","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.dld.2025.03.002_bib0036","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.36783","article-title":"Food retention at endoscopy among adults using glucagon-like peptide-1 receptor agonists","volume":"7","author":"Nasser","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.dld.2025.03.002_bib0037","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/anae.16454","article-title":"Relationship between residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound: a prospective observational study","volume":"79","author":"Nersessian","year":"2024","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1016\/j.dld.2025.03.002_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(24)00968-5","article-title":"Outcomes associated with glucagon-like peptide-1 receptor agonist use in patients undergoing outpatient upper endoscopy","volume":"166","author":"Panchal","year":"2024","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.dld.2025.03.002_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(24)01939-5","article-title":"Glucagon-like-peptide-1 receptor agonists (GLP-1 RA): impact on outpatient upper endoscopy procedure quality","volume":"166","author":"Peng","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.03.002_bib0040","doi-asserted-by":"crossref","unstructured":"Rizvi A, Salgado S, Newberry C, et al. Endoscopic gastric food retention rates for GLP-1RA users can be potentially mitigated by pre-colonoscopy fasting protocols in a propensity-matched cohort study. 2024:AB230\u20131.","DOI":"10.1016\/j.gie.2024.04.1085"},{"key":"10.1016\/j.dld.2025.03.002_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2024.111668","article-title":"Effect of various perioperative semaglutide interruption intervals on residual gastric content assessed by esophagogastroduodenoscopy: a retrospective single center observational study","volume":"99","author":"Santos","year":"2024","journal-title":"J Clin Anesth"},{"issue":"6","key":"10.1016\/j.dld.2025.03.002_bib0042","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia","volume":"159","author":"Sen","year":"2024","journal-title":"JAMA Surg"},{"issue":"8","key":"10.1016\/j.dld.2025.03.002_bib0043","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s12630-023-02549-5","article-title":"Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide","volume":"70","author":"Sherwin","year":"2023","journal-title":"Can J Anesth"},{"issue":"8","key":"10.1016\/j.dld.2025.03.002_bib0044","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/10600280211055804","article-title":"Impact of glucagon-like peptide-1 receptor agonists (GLP-1RA) on food content during esophagogastroduodenoscopy (EGD)","volume":"56","author":"Stark","year":"2022","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.dld.2025.03.002_bib0045","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.soard.2024.04.344","article-title":"Analyzing the use of Glucagon like peptide-1 agonists prior to endoscopy in bariatric patients","volume":"20","author":"Wilkes-Barre","year":"2024","journal-title":"Surg Obes Relat Dis"},{"issue":"2","key":"10.1016\/j.dld.2025.03.002_bib0046","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2024.03.015","article-title":"Increased risk of aspiration pneumonia associated with endoscopic procedures among patients with glucagon-like peptide 1 receptor agonist use","volume":"167","author":"Yeo","year":"2024","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.dld.2025.03.002_bib0047","doi-asserted-by":"crossref","first-page":"S647","DOI":"10.14309\/01.ajg.0001033068.98401.05","article-title":"EGD outcomes in patients receiving GLP-1 receptor agonists","volume":"119","author":"Young","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.dld.2025.03.002_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(24)01955-3","article-title":"Association between perioperative GLP-1 agonist use and post operative complications in patients undergoing upper endoscopy","volume":"166","author":"Zaffar","year":"2024","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.dld.2025.03.002_bib0049","doi-asserted-by":"crossref","first-page":"S599","DOI":"10.1016\/S0016-5085(16)32059-5","article-title":"Analysis of inhibitory action of glucagon like peptide-1 (GLP-1) receptor agonist on gastrointestinal motility using capsule endoscopy","volume":"150","author":"Maeda","year":"2016","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.dld.2025.03.002_bib0050","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.diabet.2017.05.009","article-title":"Effect of GLP-1 receptor agonist on gastrointestinal tract motility and residue rates as evaluated by capsule endoscopy","volume":"43","author":"Nakatani","year":"2017","journal-title":"Diabetes Metab J"},{"issue":"6","key":"10.1016\/j.dld.2025.03.002_bib0051","first-page":"695","article-title":"Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: a randomised, double-blind, placebo-controlled trial. United European","volume":"8","author":"Wegeberg","year":"2020","journal-title":"Gastroenterol J"},{"key":"10.1016\/j.dld.2025.03.002_bib0052","article-title":"Glucagon-like peptide-1 receptor agonists and capsule endoscopy in patients with diabetes: a matched cohort study","author":"Odah","year":"2024","journal-title":"Gastrointest Endosc"},{"issue":"26","key":"10.1016\/j.dld.2025.03.002_bib0053","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.3748\/wjg.v30.i26.3221","article-title":"Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study","volume":"30","author":"Ghazanfar","year":"2024","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.dld.2025.03.002_bib0054","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1210\/er.2018-00161","article-title":"Diabetic gastroparesis","volume":"40","author":"Bharucha","year":"2019","journal-title":"Endocr Rev"},{"issue":"12","key":"10.1016\/j.dld.2025.03.002_bib0055","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00125-022-05796-1","article-title":"Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control","volume":"65","author":"Jalleh","year":"2022","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.dld.2025.03.002_bib0056","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/jc.2017-02006","article-title":"Glucagon-like peptide-1 inhibits prandial gastrointestinal motility through myenteric neuronal mechanisms in humans","volume":"103","author":"Halim","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.dld.2025.03.002_bib0057","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/dom.13120","article-title":"Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity","volume":"20","author":"Hjerpsted","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.dld.2025.03.002_bib0058","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.14280","article-title":"The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity","volume":"23","author":"Friedrichsen","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.dld.2025.03.002_bib0059","article-title":"Glucagon-like peptide-1 receptor agonists do not increase aspiration during upper endoscopy in patients with diabetes","author":"Barlowe","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.03.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2023.11.024","article-title":"Low incidence of pulmonary aspiration during upper endoscopy in patients prescribed a glucagon-like peptide 1 receptor agonist","author":"Anazco","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.03.002_bib0061","article-title":"Clinical outcomes and safety of upper endoscopy while on glucagon-like peptide-1 receptor agonists","author":"Firkins","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2025.03.002_bib0062","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.thorsurg.2015.04.011","article-title":"Acute intraoperative pulmonary Aspiration","volume":"25","author":"Nason","year":"2015","journal-title":"Thorac Surg Clin"},{"issue":"8","key":"10.1016\/j.dld.2025.03.002_bib0063","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s12630-023-02521-3","article-title":"Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report","volume":"70","author":"Gulak","year":"2023","journal-title":"Can J Anesth"},{"issue":"8","key":"10.1016\/j.dld.2025.03.002_bib0064","article-title":"Particulate gastric contents in patients prescribed glucagon-like peptide 1 receptor agonists after appropriate perioperative fasting: a report of 2 cases","volume":"17","author":"Wilson","year":"2023","journal-title":"A a Pract"},{"issue":"2","key":"10.1016\/j.dld.2025.03.002_bib0065","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.bja.2023.05.005","article-title":"Clinically significant emesis in a patient taking a long-acting GLP-1 receptor agonist for weight loss","volume":"131","author":"Weber","year":"2023","journal-title":"Brit J Anaesth"},{"issue":"1","key":"10.1016\/j.dld.2025.03.002_bib0066","doi-asserted-by":"crossref","first-page":"e12278","DOI":"10.1002\/anr3.12278","article-title":"Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss","volume":"12","author":"Avraham","year":"2024","journal-title":"Anaesth Rep"},{"issue":"1","key":"10.1016\/j.dld.2025.03.002_bib0067","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/jgh.15662","article-title":"Scoring system assessing mucosal visibility of upper gastrointestinal tract: the POLPREP scale","volume":"37","author":"Romanczyk","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.03.002_bib0068","article-title":"Glucagon-like peptide receptor agonists use before endoscopy is associated with low retained gastric contents: a multicenter cross-sectional analysis","author":"Phan","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.dld.2025.03.002_bib0069","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.2337\/diabetes.54.7.2212","article-title":"Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects","volume":"54","author":"Meier","year":"2005","journal-title":"Diabetes"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825002816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825002816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:28:08Z","timestamp":1762554488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865825002816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1590865825002816"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2025.03.002","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 receptor agonists increase the risk of residual gastric content and pulmonary aspiration on upper endoscopy: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2025.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}